Literature DB >> 11344150

Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.

C Deloménie1, S Fouix, S Longuemaux, N Brahimi, C Bizet, B Picard, E Denamur, J M Dupret.   

Abstract

Arylamine N-acetyltransferase activity has been described in various bacterial species. Bacterial N-acetyltransferases, including those from bacteria of the gut flora, may be involved in the metabolism of xenobiotics, thereby exerting physiopathological effects. We characterized these enzymes further by steady-state kinetics, time-dependent inhibition, and DNA hybridization in 40 species, mostly from the human intestinal microflora. We report for the first time N-acetyltransferase activity in 11 species of Proteobacteriaceae from seven genera: Citrobacter amalonaticus, Citrobacter farmeri, Citrobacter freundii, Klebsiella ozaenae, Klebsiella oxytoca, Klebsiella rhinoscleromatis, Morganella morganii, Serratia marcescens, Shigella flexneri, Plesiomonas shigelloides, and Vibrio cholerae. We estimated apparent kinetic parameters and found that 5-aminosalicylic acid, a compound efficient in the treatment of inflammatory bowel diseases, was acetylated with a catalytic efficiency 27 to 645 times higher than that for its isomer, 4-aminosalicylic acid. In contrast, para-aminobenzoic acid, a folate precursor in bacteria, was poorly acetylated. Of the wild-type strains studied, Pseudomonas aeruginosa was the best acetylator in terms of both substrate spectrum and catalytic efficiency. DNA hybridization with a Salmonella enterica serovar Typhimurium-derived probe suggested the presence of this enzyme in eight proteobacterial and four gram-positive species. Molecular aspects together with the kinetic data suggest distinct functional features for this class of microbial enzymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344150      PMCID: PMC99640          DOI: 10.1128/JB.183.11.3417-3427.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  65 in total

1.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

2.  Frequency and spectrum of microorganisms isolated from biopsy specimens in chronic colitis.

Authors:  E Höring; D Göpfert; G Schröter; U von Gaisberg
Journal:  Endoscopy       Date:  1991-11       Impact factor: 10.093

3.  Purification and properties of the enzyme arylamine N-acetyltransferase from the housefly Musca domestica.

Authors:  D P Whitaker; M W Goosey
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

4.  Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats.

Authors:  M A Doll; D W Hein
Journal:  Pharmacogenetics       Date:  1995-08

5.  The effects of vitamin E on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.

Authors:  J G Chung
Journal:  Food Chem Toxicol       Date:  1999-06       Impact factor: 6.023

6.  Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro.

Authors:  S L Kelly; E Sim
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

7.  Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

Authors:  D W Hein; M A Doll; T D Rustan; K Gray; Y Feng; R J Ferguson; D M Grant
Journal:  Carcinogenesis       Date:  1993-08       Impact factor: 4.944

8.  [Comparative randomized open study of the efficacy and tolerance of enemas with 2 gr of 4-amino-salicylic acid (4-ASA) and 1 gr of 5-amino-salicylic acid (5-ASA) in distal forms of hemorrhagic rectocolitis].

Authors:  P Marteau; M Halphen
Journal:  Gastroenterol Clin Biol       Date:  1995-01

9.  N-acetylation and N-formylation of carcinogenic arylamines and related compounds in dogs.

Authors:  F Okumura; O Ueda; S Kitamura; K Tatsumi
Journal:  Carcinogenesis       Date:  1995-01       Impact factor: 4.944

10.  Possible mechanisms underlying the slow lactose fermentation phenotype in Shigella spp.

Authors:  H Ito; N Kido; Y Arakawa; M Ohta; T Sugiyama; N Kato
Journal:  Appl Environ Microbiol       Date:  1991-10       Impact factor: 4.792

View more
  20 in total

1.  Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.

Authors:  Isaac M Westwood; Simon J Holton; Fernando Rodrigues-Lima; Jean-Marie Dupret; Sanjib Bhakta; Martin E M Noble; Edith Sim
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 2.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

Review 3.  Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Authors:  Ian D Wilson; Jeremy K Nicholson
Journal:  Transl Res       Date:  2016-08-13       Impact factor: 7.012

4.  Structure of Mesorhizobium loti arylamine N-acetyltransferase 1.

Authors:  Simon J Holton; Julien Dairou; James Sandy; Fernando Rodrigues-Lima; Jean Marie Dupret; Martin E M Noble; Edith Sim
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-24

5.  Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.

Authors:  James Sandy; Adeel Mushtaq; Simon J Holton; Pamela Schartau; Martin E M Noble; Edith Sim
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

6.  Arylamine N-acetyltransferase responsible for acetylation of 2-aminophenols in Streptomyces griseus.

Authors:  Hirokazu Suzuki; Yasuo Ohnishi; Sueharu Horinouchi
Journal:  J Bacteriol       Date:  2006-12-08       Impact factor: 3.490

Review 7.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors:  Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal:  Nat Rev Microbiol       Date:  2016-03-14       Impact factor: 60.633

8.  Mesalazine pharmacokinetics and NAT2 phenotype.

Authors:  Hendrik Lück; Martina Kinzig; Alexander Jetter; Uwe Fuhr; Fritz Sörgel
Journal:  Eur J Clin Pharmacol       Date:  2008-08-14       Impact factor: 2.953

9.  The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.

Authors:  Vasiliki Garefalaki; Evanthia Kontomina; Charalambos Ioannidis; Olga Savvidou; Christina Vagena-Pantoula; Maria-Giusy Papavergi; Ioannis Olbasalis; Dionysios Patriarcheas; Konstantina C Fylaktakidou; Tamás Felföldi; Károly Márialigeti; Giannoulis Fakis; Sotiria Boukouvala
Journal:  World J Microbiol Biotechnol       Date:  2019-10-31       Impact factor: 3.312

10.  Molecular characterization of a novel N-acetyltransferase from Chryseobacterium sp.

Authors:  Shinji Takenaka; Kenji Yoshida; Kosei Tanaka; Ken-Ichi Yoshida
Journal:  Appl Environ Microbiol       Date:  2013-12-27       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.